Internal Medicine · Houston, TX
NPI
1457882870
Since 2017
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2130 W Holcombe Blvd Fl 10
Houston, TX, 77030
Phone (713) 600-0900
Groups this clinician bills Medicare through
Medicare paid, 2024
$864K
85,726 services
Medicare patients, 2024
240
Average age 74
Drug cost, 2024
$5.4M
2,061 prescriptions
Company payments, 2025
$7,050
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Munaf Alkadimi was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 27,030 times for 22 patients. In total Munaf Alkadimi billed 85,726 services in 102 codes, and Medicare paid $864K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 27,030 | 22 | $0.26 | $7,137 |
| 85025 Blood Count | Office | 478 | 175 | $7.57 | $3,616 |
| 99214 Office E&M - Established | Office | 339 | 170 | $101.38 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 190 | 133 | $13.95 | $2,650 |
| 96372 Injection Administration | Office | 181 | 25 | $11.64 | $2,106 |
| 96367 Intravenous Infusion, Hydration | Office | 91 | 12 | $23.46 | $2,135 |
| 36415 Venipuncture Blood Collection | Office | 85 | 32 | $8.65 | $735 |
| 96413 Chemotherapy Administration | Office | 81 | 11 | $107.50 | $8,708 |
| 96365 Intravenous Infusion, Hydration | Office | 72 | 28 | $49.47 | $3,562 |
| 99213 Office E&M - Established | Office | 53 | 53 | $58.61 | $3,106 |
| 99441 Telephone Services | Office | 24 | 23 | $33.14 | $795 |
| 99204 Office E&M - New | Office | 24 | 24 | $143.65 | $3,448 |
| 99215 Office E&M - Established | Office | 22 | 15 | $152.94 | $3,365 |
| 99442 Telephone Services | Office | 12 | 11 | $62.37 | $748 |
By year: 2022 $3,904 for 36 services; 2023 $80K for 17,868 services; 2024 $864K for 85,726 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 478 | 175 | $7.57 | $3,616 |
| 36415 Venipuncture Blood Collection | 85 | 32 | $8.65 | $735 |
Medicare prescription drug claims, 2024
In 2024, the drug Munaf Alkadimi prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 151 prescriptions and refills. In total Munaf Alkadimi wrote 2,061 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 151 | 151 | 51 | $5,036 |
| Anastrozole Generic | 130 | 370 | 52 | $1,915 |
| Eliquis Apixaban | 95 | 126 | 26 | $74K |
| Hydroxyurea Generic | 91 | 197 | 26 | $3,282 |
| Ondansetron Odt Ondansetron | 64 | 67 | 47 | $2,164 |
| Dexamethasone Generic | 64 | 71 | 26 | $1,087 |
| Prednisone Generic | 62 | 84 | 19 | $245 |
| Famciclovir Generic | 57 | 91 | 16 | $3,306 |
| Abiraterone Acetate Generic | 56 | 60 | Under 11 | $134K |
| Letrozole Generic | 52 | 110 | 15 | $752 |
| Revlimid Lenalidomide | 52 | 52 | Under 11 | $861K |
| Xarelto Rivaroxaban | 48 | 105 | 13 | $58K |
| Exemestane Generic | 44 | 120 | 17 | $9,655 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 40 | 40 | 33 | $394 |
| Olanzapine Generic | 39 | 42 | 20 | $258 |
Brand drugs: 540 claims; generic drugs: 1,521 claims; opioid claims: 231.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Munaf Alkadimi $7,050 ($7,050 in general payments such as food, travel and fees) from 37 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,921.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $3,921 |
| Incyte Corporation INCY | 2 | $883 |
| Janssen Biotech, Inc. JNJ | 9 | $243 |
| Pfizer Inc. PFE | 7 | $166 |
| Merck Sharp & Dohme LLC MRK | 5 | $141 |
| Celgene Corporation BMY | 5 | $118 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $116 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $107 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $88.57 |
| Lilly USA, LLC LLY | 3 | $84.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.